ELOVL5 Participates in Embryonic Lipid Determination of Cellular Membranes and Cytoplasmic Droplets
Open Access
- 28 January 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (3), 1311
- https://doi.org/10.3390/ijms22031311
Abstract
Embryonic lipids are crucial for the formation of cellular membranes and dynamically participate in metabolic pathways. Cells can synthesize simple fatty acids, and the elongation of fatty acids facilitates the formation of complex lipids. The aim of this work was to investigate the involvement of the elongation of very long chain fatty acid enzyme 5 (ELOVL5) in embryonic development and lipid determination. Bovine embryos were produced in vitro using a standard protocol and randomly divided to receive one of three treatments at Day 4: morpholino (Mo) gene expression knockdown assay for ELOVL5 (ELOVL5-Mo), Mo antisense oligonucleotides for the thalassemic β-globulin human mRNA (technical control Mo), and placebo (biological control). The phenotypes of embryonic development, cell number, ELOVL5 protein abundance, lipid droplet deposits, and lipid fingerprint were investigated. No detrimental effects (p > 0.05) were observed on embryo development in terms of cleavage (59.4 ± 3.5%, 63.6 ± 4.1%, and 65.4 ± 2.2%), blastocyst production (31.3 ± 4.2%, 28.1 ± 4.9%, and 36.1 ± 2.1%), and blastocyst cell number (99.6 ± 7.7, 100.2 ± 6.2, 86.8 ± 5.6), respectively, for biological control, technical control Mo, and ELOVL5-Mo. ELOVL5 protein abundance and cytoplasmic lipid droplet deposition were increased (p < 0.05) in ELOVL5-Mo–derived blastocysts compared with the controls. However, seven lipid species, including phosphatidylcholines, phosphatidylethanolamines, and triacylglycerol, were downregulated in the ELOVL5-Mo–derived blastocysts compared with the biological control. Therefore, ELOVL5 is involved in the determination of embryonic lipid content and composition. Transient translational blockage of ELOVL5 reduced the expression of specific lipid species and promoted increased cytoplasmic lipid droplet deposition, but with no apparent deleterious effect on embryonic development and blastocyst cell number.Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (446647/2014-4)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (financial code 1)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2012/07206-0, scholarship)
This publication has 49 references indexed in Scilit:
- Cryotolerance and global gene-expression patterns of Bos taurus indicus and Bos taurus taurus in vitro- and in vivo-produced blastocystsReproduction, Fertility and Development, 2014
- MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysisNucleic Acids Research, 2012
- Single embryo and oocyte lipid fingerprinting by mass spectrometryJournal of Lipid Research, 2010
- Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantationJournal of Lipid Research, 2009
- Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in miceJournal of Lipid Research, 2009
- A Primer for Morpholino Use in ZebrafishZebrafish, 2009
- Gene doping: the hype and the realityBritish Journal of Pharmacology, 2008
- Controlling morpholino experiments: don't stop making antisenseDevelopment, 2008
- Membrane lipids: where they are and how they behaveNature Reviews Molecular Cell Biology, 2008
- Lipid signaling in embryo implantationProstaglandins & Other Lipid Mediators, 2005